# OnCo record acacia-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/acacia-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "acacia-pharma" ;
  schema:name "Acacia Pharma"@en ;
  schema:alternateName "Acacia Pharma Ltd"@en, "Acacia Pharma Group"@en ;
  schema:description "Acacia Pharma was a Cambridge company that repurposed the old antipsychotic amisulpride, at low dose, to prevent and treat nausea and vomiting after surgery and chemotherapy; it was bought by Eagle Pharmaceuticals in 2022."@en ;
  schema:url <https://onco.cc/companies/acacia-pharma/>, <http://www.acaciapharma.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <http://www.acaciapharma.com>, <https://clinicaltrials.gov/search?lead=Acacia%20Pharma%20Ltd>, <https://www.wikidata.org/wiki/Q30268747> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "GB" ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/antiemetic-therapy/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> ;
  onco:trials <https://onco.cc/trials/nct04851717/> .